"I do not see the stock price jumping above $3 (on positive results) before a real manufacturing plan/partnership is developed/inked.  Shareholders will be diluted a few times more times before any of that will happen, hence the issuance of warrants on both these recent raises."

RVX closed at $1.50 CAD today with a market cap of ~$266M CAD million. Your $3 share projection on positive results would put the market cap at ~$550M CAD (higher with some dilution). We've discussed this issue before, so I won't belabor it. But just ask yourself a few questions. How much is a Phase 3 drug worth that posts positive results in a cardiovascular outcomes trial? How much media and investor excitement would be generated with this successful CVOT news? Then please re-consider your projection. Jeesh! I thought Growacet's $1 billion market cap projection was low.

BDAZ